Melanoma/Skin Cancer News

Many patients with early onset Merkel cell carcinoma have genetic variants leading to possible increased cancer risks and should receive genetic counseling and testing, according to a study.

The percentage of patients with advanced cancers who died within a month of beginning immunotherapy rose significantly in the last decade, study results published in JAMA Oncology showed.

Combination cryosurgery and topical 5-fluorouracil may be a better treatment alternative to invasive procedures for patients with low-risk nonmelanoma skin cancer, according to a study.

Only about one-fourth of patients newly diagnosed with advanced cancers had documented conversations with their physicians about the costs of care, according to a study conducted by researchers at American Cancer Society and NCI.

AiViva Biopharma has completed a phase 1/2 trial of AIV001, a nonsurgical treatment for basal cell carcinoma, the company announced in a press release.

Adjuvant treatment with messenger RNA in combination with Keytruda produced meaningful improvement in patients with resected high-risk melanoma, according to findings from a phase 2b study.

Histopathologic regression of melanoma may be associated with favorable outcomes in patients eligible for sentinel lymph node biopsy and those with irresectable melanoma receiving immune checkpoint inhibitor therapy, according to a study.

Patients diagnosed with melanoma as an adolescent or child were more likely to have a family history of melanoma or have undergone radiation therapy, according to a study.

For individuals diagnosed with cancer, guideline-concordant exercise reduced all-cause mortality by 25% compared with patients with cancer who did not exercise, study results published in Journal of Clinical Oncology showed.

A device using elastic-scattering spectroscopy and artificial intelligence may assist primary care physicians in the quick and accurate detection of skin cancer, according to a study.